یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references.
یادداشتهای مربوط به مندرجات
متن يادداشت
Intro; Presentation; Contents; Contributors; Part I: Neurotransmission and Psychopathology; 1: Substances of Abuse and Hallucinogenic Activity: The Dopaminergic Pathway -- Focus on Cocaine and Amphetamine-type Stimulants; 1.1 Focus on Cocaine; 1.1.1 Molecular Mechanism; 1.1.2 Conclusions; 1.2 Focus on Amphetamine-Type Stimulants; 1.2.1 Molecular Mechanism; 1.2.2 Conclusions; References; 2: Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway -- Focus on Classical Hallucinogens and Entactogens; 2.1 Focus on Classical Hallucinogens; 2.1.1 Molecular Mechanism
متن يادداشت
2.1.2 Conclusions2.2 Focus on Entactogens; 2.2.1 Molecular Mechanism; 2.2.2 Conclusions; References; 3: Substances of Abuse and Hallucinogenic Activity: The Glutamatergic Pathway -- Focus on Ketamine; 3.1 Focus on Ketamine; 3.1.1 Molecular Mechanism; References; 4: Chronic Hallucinatory Disorder "an Equivalent" of Delusional Disorder; 4.1 Introduction; 4.2 Hallucinatory Disorder: Clinical Picture; 4.3 Hallucinatory Disorder: Neurocognitive Aspects; 4.4 Hallucinatory Disorder: Neuroimaging Data; References; 5: Hallucinations in the Substance-Induced Psychosis; 5.1 Introduction
6: Hallucinatory Symptomatology in Major Psychoses (Schizophrenia and Bipolar Disorders)6.1 Introduction; 6.2 Hallucinations in Bipolar Disorder Versus Schizophrenia: A Concise Look at the Status of Comparative Empirical Research; 6.3 A Phenomenological Reappraisal of BD and Schizophrenia; 6.4 The Psychotic Syndrome as a Trajectory; References; 7: Hallucinations in Neurological Disorders; 7.1 Hypnic Hallucinations (HH); 7.2 Peduncular Hallucinosis (PH); 7.3 Charles Bonnet Syndrome (CBS); 7.4 Migraine; 7.5 Epilepsy; 7.6 Intellectual Disability; 7.7 Neurodegenerative Disorders
متن يادداشت
7.7.1 Alzheimer's Disease (AD)7.7.2 Parkinson's Disease (PD); 7.7.3 Dementia with Lewy Bodies (DLB); 7.7.4 Frontotemporal Dementia (FTD); 7.8 Prion Diseases; 7.9 Hallucinations Associated with Other Medical Conditions; 7.9.1 Delirium; 7.9.2 Paraneoplastic Neurological Syndromes; 7.9.3 Systemic Lupus Erythematosus (SLE); 7.9.4 Hashimoto's Encephalopathy; 7.9.5 Behçet's Syndrome; 7.9.6 Neurosyphilis; 7.9.7 Inborn Errors of Metabolism; References; Part II: Genetics and Neuroimaging; 8: Genetic Basis of Auditory Verbal Hallucinations in Schizophrenia; 8.1 Introduction
بدون عنوان
0
بدون عنوان
8
بدون عنوان
8
بدون عنوان
8
بدون عنوان
8
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
This book presents state of the art knowledge on the psychopathology, clinical symptomatology, biology, and treatment of hallucinations in patients with psychoses and affective disorders. The opening section describes and examines the origins of the hallucinatory symptoms associated with schizophrenia, bipolar disorders, and drug- or substance-induced psychoses. In addition, progress in understanding of hallucinations in children and adolescents and chronic hallucinatory disorder is reviewed, and the value of a Research Domain Criteria approach in elucidating the emergence of auditory hallucinations is explained. The biological basis of hallucinations is then closely scrutinized with reference to recent genetic research, neurochemical studies, and functional and structural neuroimaging data. Outcomes of a meta-analysis of diffusion tensor imaging studies regarding the association between white matter integrity and auditory verbal hallucinations are highlighted. The closing chapters focus on the roles of drug treatment and electric and magnetic brain stimulation techniques. The book will be of wide interest to psychiatrists and clinical psychologists.
یادداشتهای مربوط به سفارشات
منبع سفارش / آدرس اشتراک
Springer Nature
شماره انبار
com.springer.onix.9783319751245
ویراست دیگر از اثر در قالب دیگر رسانه
عنوان
Hallucinations in psychoses and affective disorders.